par Luc St-Pierre | Mai 4, 2020 | Non classé
PreveCeutical Announces Possible Viral Prevention Program Using CBD Sol-gel Vancouver, British Columbia–(Newsfile Corp. – May 4, 2020) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (« PreveCeutical »), is pleased to announce...
par Luc St-Pierre | Mai 4, 2020 | Non classé
CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of Head and Neck Cancer CEL-SCI Corporation (NYSE American: CVM) announced today that it has been notified that it has reached the targeted threshold...
